Publication date: Available online 4 September 2020Source: Allergology InternationalAuthor(s): Yoichi Nakamura, Jun Tamaoki, Hiroyuki Nagase, Masao Yamaguchi, Takahiko Horiguchi, Soichiro Hozawa, Masakazu Ichinose, Takashi Iwanaga, Rieko Kondo, Makoto Nagata, Akihito Yokoyama, Yuji Tohda, The Japanese Society of Allergology
Sat Sep 05, 2020 14:52
Abstract The continuous search for novel allergens and the design of allergen derivatives improves the understanding of their allergenicity and aids the design of novel diagnostic and immunotherapy approaches. This article discusses the recent developments in allergen and epitope discovery, allergy diagnostics and immunotherapy. Structural information is crucial for elucidation of the cross‐reactivity of marker allergens such as the walnut Jug r 6 or that of non‐homologous allergens, as shown for...
Thu Sep 03, 2020 11:10
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s):
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s): Marc E. Rothenberg, Jean Bousquet
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s): Zuhair K. Ballas, Associate Editors of the JACI
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s): Hans-Hartmut Peter, Hans D. Ochs, Charlotte Cunningham-Rundles, Donald C. Vinh, Peter Kiessling, Bernhard Greve, Stephen Jolles
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s): Dhavalkumar D. Patel, James B. Bussel
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s):
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s):
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s):
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s):
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s):
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s):
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s):
Sat Sep 05, 2020 16:11
Publication date: September 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 3Author(s):
Sat Sep 05, 2020 16:11
Allergic bronchopulmonary aspergillosis (ABPA) reflects hypersensitivity and an exaggerated immune response to Aspergillus fumigatus. ABPA typically occurs in individuals with airway diseases such as asthma or cy...
Thu Sep 03, 2020 03:00
Monitoring the effects of biologic therapies in skin diseases will benefit from alternative nonivasive skin sampling techniques to examine immune pathways in diseased tissue early and longitudinally.
Fri Sep 04, 2020 03:00
Evaluation of drug allergy is intricate because of nonstandardized testing and challenge method variability.
Fri Sep 04, 2020 03:00
Abstract Purpose of Review Intranasal corticosteroid sprays have been available as over-the-counter (OTC) medications since 2013. As such, clinicians need to be up-to-date with the risks and the safety of INS, as patients may have concerns and detailed questions. The following is a review of the recent medical literature regarding the safety profile, adverse reactions, and special populations using INS. ...
03:00
Abstract Purpose of the Review We provide a systematic review of experimental and clinical evidences linking allergy to acute, including common cold, and chronic rhinosinusitis in children. Furthermore, we questioned if anti-allergy treatment may prevent the occurrence of rhinosinusitis or improve outcomes of its specific management. Recent Findings ...
Sat Sep 05, 2020 03:00
Background Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP), and aspirin‐exacerbated respiratory disease (AERD) have varying levels of inflammation and disease severity. Solitary chemosensory cells (SCCs) are enriched in nasal polyps, are the primary source of interleukin 25 (IL‐25) in upper airways, leading to type 2 inflammation, and are activated by bitter‐tasting denatonium benzoate (DB). Thus, we sought to evaluate DB taste perception at a range...
Thu Sep 03, 2020 18:45
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου